Aquestive Therapeutics, Inc. — Director's Dealing 2021

Mar 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2021-03-11

Reporting Person: TOTH A ERNEST JR (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-11	Non-Qualified Stock Option (right to buy)	$5.30	A	2500	Acquired	2031-03-11	Common Stock (2500)	Direct

Footnotes

F1: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.